Huntingdon Life Sciences and Harlan Laboratories to become Envigo

The combined company has been created through the integration of Huntingdon Life Sciences and Harlan Laboratories, and three subsidiaries: GFA, NDA Analytics and LSR associates.

Huntingdon (UK) Huntingdon Life Sciences (HLS) and Harlan Laboratories have announced that the combined companies will be called Envigo (pronounced En-vee-go.)

When the new name and brand is launched later this year it will be a significant milestone for the combined organization, marking great progress in integrating the companies and building on a heritage of more than 80 years.

The name Envigo is made from a combination of words that reflect the identity of the new company. The letters "E and N" come from "enhance, enrich and enable," … the company helps make the world a better place through advancing the research and product development of its customers. "VIGO" originates in "vigorous and invigorate", and the Latin word "vita" meaning "life"… so being dynamic and strong, imparting vitality, energy and life.

Brian Cass, CEO, commented: "This is a hugely exciting time for our company. We at Envigo will be united with our customers in the knowledge that the research they conduct, and the products we help them develop, have the potential to enhance life. Our new name and brand will reflect our integrated management structure and the broader product and service offerings of our combined organization."

Adrian Hardy, COO, added: "Our customers are looking for partners who understand their goals, take ownership of projects, and deliver high quality products and science. Our goal is to establish Envigo as the number one partner for both customer service and scientific expertise."

The combined organization has 3,800 people and sales approaching $500 million. As a result of the integration, the company is the largest provider of research services to the crop protection and chemical industries, the second largest supplier of research models and services, and the third largest in the preclinical pharmaceutical development arena.


Notes to editors

About Huntingdon Life Sciences

Huntingdon Life Sciences is a privately held global provider of essential non-clinical contract research services to the pharmaceutical, crop protection and chemical industries.


About Harlan Laboratories

Harlan Laboratories, Inc. is a leading provider of non-clinical contract research, research models and services, animal diets and products, as well as services to the pharmaceutical, biotech, medical device, crop protection and chemical industries, universities, government, and other research organizations.


For media enquiries, please contact:

Alex Heeley or Tristan Jervis

De Facto Communications

T: +44 771 363 8396

E: [email protected]  / [email protected]


Company contacts:

Andrew Gay at Huntingdon Life Sciences

Phone: + 44 (0) 1480 893073 Email: [email protected]

Katie Bramwell at Huntingdon Life Sciences

Phone: +44 (0) 1480 892748 Email: [email protected]

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.